Description
NSE cancels the planned suspension of trading in Shree Ram Proteins Limited securities effective August 28, 2025.
Summary
NSE has decided to cancel the planned suspension of trading in Shree Ram Proteins Limited (SRPL) securities, which was originally scheduled due to non-compliance with board composition requirements under SEBI Listing Regulations.
Key Points
- Trading suspension for SRPL securities has been cancelled effective August 28, 2025
- Original suspension was planned due to non-compliance with Regulation 17(1) regarding board composition
- Non-compliance occurred for two consecutive quarters: December 31, 2024 and March 31, 2025
- This reverses the decision announced in earlier circular 1371/2025 dated July 28, 2025
Regulatory Changes
No regulatory changes - this is a reversal of a previously announced enforcement action.
Compliance Requirements
No new compliance requirements specified. The cancellation suggests SRPL may have addressed the board composition issues.
Important Dates
- August 28, 2025: Effective date for cancellation of trading suspension
- July 28, 2025: Date of original suspension announcement (Circular 1371/2025)
- December 31, 2024 & March 31, 2025: Quarters during which non-compliance occurred
Impact Assessment
Positive impact for SRPL shareholders and investors as normal trading operations will continue without interruption. The cancellation indicates the company likely resolved its board composition compliance issues.
Impact Justification
Positive development for SRPL shareholders as trading suspension is cancelled, allowing normal trading to resume